China has banned the sale of a pharmaceutical company in
northeast China's Heilongjiang Province, accusing an injection
fluid it produces of causing kidney failure.
All of medicines produced by Qiqihar No. 2 pharmaceutical Co.,
Ltd. have been banned from marketing or using and sealed up for
investigation following reports that its Armillarisni. A Injection
may cause kidney exhaustion, as required by the State Food and Drug
Administration.
On May 3, drug authorities in south China's Guangdong Province reported that patients
using the injection fluid have acute kidney failure symptoms.
The medicine is mainly for treating acute or chronic
cholecystitis and chronic and atrophic gastritis.
Investigators have gone to Heilongjiang, Guangdong and Jiangsu provinces, where raw materials of the
medicine are from, with initial results indicating that the
medicine is fake as the production process has safety problems.
Police has stepped in to further the investigation.
(Xinhua News Agency May 13, 2006)